IntegraGen SA (EPA:ALINT)

IntegraGen Statistics

Total Valuation

IntegraGen has a market cap or net worth of EUR 1.66 million. The enterprise value is 851,243.

Market Cap	1.66M
Enterprise Value	851,243

Important Dates

The next estimated earnings date is Thursday, September 17, 2026.

Earnings Date	Sep 17, 2026
Ex-Dividend Date	n/a

Share Statistics

IntegraGen has 6.59 million shares outstanding.

Current Share Class	6.59M
Shares Outstanding	6.59M
Shares Change (YoY)	n/a
Shares Change (QoQ)	n/a
Owned by Insiders (%)	n/a
Owned by Institutions (%)	n/a
Float	n/a

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	0.33
PB Ratio	-1.83
P/TBV Ratio	n/a
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	-0.32
EV / Sales	0.17
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	-0.54

Financial Position

The company has a current ratio of 0.95

Current Ratio	0.95
Quick Ratio	0.85
Debt / Equity	n/a
Debt / EBITDA	n/a
Debt / FCF	-0.19
Interest Coverage	-1,473.37

Financial Efficiency

Return on equity (ROE) is -629.40% and return on invested capital (ROIC) is -191.76%.

Return on Equity (ROE)	-629.40%
Return on Assets (ROA)	-41.35%
Return on Invested Capital (ROIC)	-191.76%
Return on Capital Employed (ROCE)	-21,127.27%
Weighted Average Cost of Capital (WACC)	5.30%
Revenue Per Employee	135,701
Profits Per Employee	-71,996
Employee Count	37
Asset Turnover	1.21
Inventory Turnover	23.72

Taxes

Income Tax	-91,787
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -56.75% in the last 52 weeks. The beta is 0.35, so IntegraGen's price volatility has been lower than the market average.

Beta (5Y)	0.35
52-Week Price Change	-56.75%
50-Day Moving Average	0.19
200-Day Moving Average	0.18
Relative Strength Index (RSI)	56.44
Average Volume (20 Days)	58,399

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, IntegraGen had revenue of EUR 5.02 million and -2.66 million in losses. Loss per share was -0.40.

Revenue	5.02M
Gross Profit	1.06M
Operating Income	-2.75M
Pretax Income	-2.76M
Net Income	-2.66M
EBITDA	-2.71M
EBIT	-2.75M
Loss Per Share	-0.40

Balance Sheet

The company has 1.12 million in cash and 304,597 in debt, with a net cash position of 810,605 or 0.12 per share.

Cash & Cash Equivalents	1.12M
Total Debt	304,597
Net Cash	810,605
Net Cash Per Share	0.12
Equity (Book Value)	-908,525
Book Value Per Share	-0.14
Working Capital	-140,634

Cash Flow

In the last 12 months, operating cash flow was -1.58 million and capital expenditures -2,266, giving a free cash flow of -1.58 million.

Operating Cash Flow	-1.58M
Capital Expenditures	-2,266
Depreciation & Amortization	44,703
Net Borrowing	748,713
Free Cash Flow	-1.58M
FCF Per Share	-0.24

Margins

Gross margin is 21.14%, with operating and profit margins of -54.82% and -53.05%.

Gross Margin	21.14%
Operating Margin	-54.82%
Pretax Margin	-54.88%
Profit Margin	-53.05%
EBITDA Margin	-53.93%
EBIT Margin	-54.82%
FCF Margin	n/a

Dividends & Yields

IntegraGen does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	n/a
Shareholder Yield	n/a
Earnings Yield	-160.29%
FCF Yield	-94.95%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

IntegraGen has an Altman Z-Score of -3.23 and a Piotroski F-Score of 3. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	-3.23
Piotroski F-Score	3